Overview
Asahi Kasei Bioprocess, under Asahi Kasei Life Science established in April 2025, provides virus removal filters like Planova™ and Microfilters BioOptimal™, along with CRO testing services via ViruSure and Bionique, and CDMO services through Bionova Scientific. These solutions support viral safety in cell culture media, downstream biopharmaceutical manufacturing, and emerging biologics modalities. The company is expanding Planova™ production capacity with a new facility in Japan starting operations in 2030 to meet global demand.
Frequently asked questions
- What bioprocess products does Asahi Kasei Bioprocess offer?
- Key offerings include Planova™ virus removal filters (S20N, 15N, 20N, 35N, 75N), Microfilters BioOptimal™, and equipment for viral safety in biologics manufacturing and cell culture media.
- What are your CRO and CDMO capabilities?
- CRO testing services through ViruSure (Austria, acquired 2019) and Bionique (U.S., acquired 2021); CDMO services via Bionova Scientific (U.S., acquired 2022) for bioprocess development and manufacturing.
- Where are your manufacturing and service locations?
- Manufacturing in Japan (Nobeoka City for Planova™ filters, new plant by 2030); CRO in Austria and U.S.; CDMO in U.S., supporting global bioprocess supply chains.